Improvement of sympathetic skin responses under enzyme replacement therapy in Fabry disease.

Abstract excerpt

AIM: To report the effect of enzyme replacement therapy (ERT) in sympathetic skin responses (SSR) of patients with Fabry disease. PATIENTS AND METHODS: Seven male patients were included in an open-label protocol using agalsidase-alfa, continued at regular intervals. Five patients completed 24 months of ERT and two of them completed 18 months. Two main measurements were performed at baseline, as well as 1 and 2...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age Factors
• Share to alpha-Galactosidase